
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103
Author(s) -
Chaitra S. Ujjani,
SinHo Jung,
Brandelyn N. Pitcher,
P. G. Martín,
Sophie Park,
Kristie A. Blum,
Sonali M. Smith,
Myron S. Czuczman,
Matthew S. Davids,
Ellis Levine,
Lionel D. Lewis,
Scott E. Smith,
Nancy L. Bartlett,
John P. Leonard,
Bruce D. Cheson
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/mbvm-5959
Subject(s) - lenalidomide , ibrutinib , rituximab , follicular lymphoma , medicine , follicular phase , oncology , lymphoma , chronic lymphocytic leukemia , leukemia , multiple myeloma